INTRODUCTION
Bidirectional cell transfer between mother and fetus was first recognized decades ago and is now known to be a common event [1, 2] . The persistence of transferred cells has been shown to lead to long-term maternal and fetal microchimerism in the blood of the child and the mother, respectively [3] [4] [5] [6] . Subsequent studies demonstrated that both fetal and maternal microchimerism (MMc) can also be found in tissues from patients with autoimmune diseases or congenital anomalies [7] [8] [9] [10] [11] [12] [13] . The frequency and phenotypes of MMc in normal tissues, however, have not been reported.
Iatrogenic chimerism occurs in transplantation, and when graft-versus-host disease (GVHD) was first recognized as a complication of hematopoietic cell transplantation, its similarities to autoimmune diseases were described [14, 15] . Naturally acquired microchimerism has thus been hypothesized to be involved in the pathogenesis of autoimmune diseases [16] . Maternal microchimerism in the newborn is likely benign or may be beneficial, but it may also transmit malignancy or cause GVHD [17] . Fetal microchimerism (FMc) has been investigated in a number of autoimmune diseases, including systemic sclerosis, primary biliary cirrhosis, thyroid disease, and systemic lupus erythematosus [5] .
Long-term MMc was first reported in immunecompetent individuals and in the peripheral blood of systemic sclerosis (SSc) patients and healthy subjects [4] and has since been identified in additional SSc patients [18] and in the target organs and blood in patients with neonatal lupus syndrome (NLS) [12] and myositis [7, 8] .
In an early study, maternal DNA was found to be increased in prevalence and in blood levels in patients with systemic sclerosis [18] . Maternal microchimerism was found in tissues that were targets of disease in 1 patient, but it was also found in tissues that were not involved. That the levels of MMc were 10-fold to 20-fold higher in the tissues than in the blood indicates that future studies into the mechanisms for the role of maternal cells in inflammatory disease may be best directed toward the parenchymal and immunological cells within the target organs. In older children, 2 groups have reported increased female cells (presumed maternal) in muscle biopsies from male patients with idiopathic myositis, compared to controls [7, 8] . Moreover, MMc in the blood was also increased in myositis patients, as detected by nested polymerase chain reaction assay for maternal human leukocyte antigen (HLA) alleles not shared with the patient [7] . Maternal microchimerism has also been demonstrated in pityriasis lichenoides, in which female cells in the form of keratinocytes were found in 11 of 12 male patients in skin biopsies [19] . T lymphocytes, antigen presenting cells, and B lymphocytes have been found in the affected skin of localized scleroderma patients, but also in controls [20] . Thus, it is not clear what variety of allogeneic cell roles maternal cells may play in the blood or tissues of children with autoimmune diseases. Maternal microchimerism is not found in every suspected disease-for instance, infantile hemangioma, hypothesized to be placental-derived maternal endothelial cells, was investigated but not found associated with MMc [21] .
In GVHD interactions between host and nonhost cells lead to chronic inflammation. Because there is usually genetic disparity between maternal and fetal cells, naturally acquired microchimerism could also potentially lead to chronic inflammation. However, although levels of MMc and FMc have been shown in some studies to be higher in patients with autoimmune diseases, both FMc and MMc are common in the blood of healthy controls. Also, unlike GVHD, in which the dominant leukocyte population is foreign, blood MMc and FMc exists at very low levels (1 chimeric cell per 10 4 to 10 6 host cells). Therefore, it is difficult to envision a mechanism by which such a tiny number of foreign cells would contribute to autoimmune disease as immune effector cells. An alternative possibility is that tissue-specific microchimeric cells act as target cells, stimulating chronic inflammation, as in a low-level chronic infection.
The phenotypes of microchimeric maternal cells in tissues have not been well characterized. Because only circulating cells pass between the mother and fetus, the most predictable phenotype would be hematopoietic. Transplanted circulating hematopoietic stem cells, however, can differentiate into tissue-specific cells and take up residence in the new host organs as hepatocytes, neurons, myocytes, and endothelial cells forming blood vessels [22] . In previous studies we identified maternal cells with the phenotypes of myocardial cells in infants with NLS who died of congenital heart block and in bislet cells in pancreas with and without type I diabetes, indicating the possibility of maternal cells differentiating in situ within fetal organs [12, 13] . In the present study we investigated multiple other tissue types for MMc and asked whether maternal cells were infiltrating inflammatory cells or were differentiated cells incorporated within the tissue architecture. We also examined the milieu of chimeric maternal cells to ask if MMc is associated with inflammation.
METHODS

Tissue samples
The Seattle Children's Hospital and Fred Hutchinson Cancer Research Center Internal Review Boards approved the protocol. All samples studied derived from 7 autopsied male subjects obtained from the archives of the Department of Pathology at the Children's Hospital that were used previously for a related study [12] . Only male subjects were used, because the approach employed identifies sex chromosome markers distinguishing female (presumed maternal) cells in male (child) tissue. Table 1 includes clinical and pathologic data for each subject. The ages of the subjects ranged from birth to 4.5 months. Five of the 7 subjects were born prematurely (27 to 36 weeks in gestation). Three subjects had died of NLS congenital heart block (subjects 1 through 3); one subject also had thrombocytopenia and hepatitis (subject 2) and another had Parvovirus (subject 3). The other subjects died of sepsis, fetal hydrops, and congenital anomalies (subjects 4 through 7). Subjects 2, 5, and 6 had transfusions of irradiated blood. Because of the archival nature of the specimens, not all clinical histories or tissue types were available for all subjects.
Simultaneous fluorescence in situ hybridization (FISH) and immunohistochemistry to phenotype maternal cells
Tissue sections from all available organs for each subject were first subjected to 2-color immunohistochemistry with 2 different specific antibodies; the same section was then probed for X-and Y-chromosomes. The antibody stains were retained throughout the FISH procedure so that light microscopy and fluorescence microscopy could be used simultaneously to characterize female cells in male tissues. The method has an advantage over previous methods, in which adjacent tissue sections were probed for X-and Y-chromosomes and tissue-specific antigens, and estimates were made to determine the phenotypes of specific cells based on location and surrounding morphology. Table 2 lists the antigens targeted to characterize specific tissue types. Antibodies to CD45 were used to identify hematopoietic cells (Dako Laboratories, Carpinteria, CA, USA); antibodies to insulin for b-islet cells (ICN Biomedicals, Inc, Irvine, CA, USA); antibodies to glucagon for a-islet cells (Sigma-Aldrich, St Louis, MO, USA); antibodies to CAM 5.2 or AE3 for cytokeratins on hepatocytes, cholangiocytes, and renal tubular cells (BD-Pharmingen, San Diego, CA, USA); and antibodies to sarcomeric a-actin for myocytes (Sigma-Aldrich). Immunohistochemistry was performed with a streptavidinconjugated secondary antibody-mediated peroxidase development system (Elite Universal Vectastain ABC Kit, Vector Laboratories, Burlingame, CA, USA) and developed with substrates SG (Vector Laboratories, blue-gray in color) and DAB (BioFX Labs, Owing Mills, MD, USA). A significant strength of this approach is that it includes an additional internal control, since cells staining for tissue-specific antigens can readily be shown to not express CD45, which was used for each tissue in combination with antibodies for parenchymal cells, and can therefore be shown to not be overlying hematopoietic cells, and vice versa.
The FISH method previously described was used to probe the tissue sections for X-and Y-chromosome sequences [12] . The probe for the X-chromosome centromere-associated marker DXZ1 was labeled with orange fluorescent Cy3-linked 29-deoxyuridine 59-triphosphate (dUTP; Amersham-Pharmacia, Piscataway, NJ, USA). The probe for the Y-chromosome satellite sequence DYZ1 was labeled with green fluorescent fluorescein isothiocyanate-linked dUTP (Roche Laboratories, Indianapolis, IN, USA). The sections were mounted in Vectashield (Vector Laboratories) with 49,69-diamidino-2-phenylindole hydrochloride (100 ng/ ml, Sigma-Aldrich) and then analyzed by fluorescence microscopy using a triple band filter specific for fluorescein, Cy3, and 49,69-diamidino-2-phenylindole hydrochloride. The tissues were visualized with a NIKON LABOPHOT-2 microscope, and photographs taken with a NIKON Coolpix 995 camera. The photos were processed using Adobe Photoshop Elements on a Macintosh G3. Photographs were edited using only cropping and the brightness/contrast and white point/black point functions for the full photographs (not selected areas). In some cases photographs taken with the green filter were overlaid with the red-green-blue filter.
To quantify the microchimeric cells, at least 2000 nuclei from each tissue section were scored. Only clearly defined nuclei with 2 obviously distinctive signals (XX or XY) were counted. Nuclei with more than 2 signals (for example, XXX, XXXX) were rarely observed in pancreas and liver but were not believed to be products of fusion, as we never observed XXXY cells. Moreover, tetraploid hepatocytes and pancreatic cells have been reported but were usually binucleate, twice as large as monoploid cells, and were found at older ages [23, 24] . The efficiency of the FISH probes, as defined by the percentage of all nuclei with 2 visible sex chromosome signals, varied with specific sections and tissues because of different fixation times prior to paraffinization, immunohistochemistry conditions, and tissue fragility. The efficiency of FISH signals for each tissue and target antigen is shown in Table 2 .
RESULTS
Female cells, presumed to be maternal, were identified in all tissues examined, including the liver, kidney, pancreas, lung, bladder, skin, and spleen, and in all subjects. We have previously shown MMc in the heart [12] . The percentages of maternal cells within each cell type are summarized in Figure 1 . In the liver, 6 of 7 subjects tested had female nuclei with 2 clearly distinguished Xchromosomes, and female nuclei constituted 0.05% to 0.2% of all nuclei examined. The kidney harbored maternal cells at a level of 0.1% to 0.9%. In the pancreas 2 of 4 subjects had maternal cells at levels of 0.05% to 0.25%. Maternal cells were found in the lung at levels of 0.05% to 0.1% and in the skin and bladder at a level of 0.05%. Because the liver and the spleen are hematopoietic organs in the fetus, we considered whether maternal hematopoietic cells might home to these organs. Only 1 of 4 spleens, however, harbored maternal cells.
To determine the phenotypes of the maternal cells within infant tissues, we used FISH for X-and Ychromosomes with immunohistochemistry for specific cell types. In the liver we stained for cytokeratins expressed by hepatocytes and biliary epithelia. We found that 42% of the maternal cells identified expressed the cytokeratin recognized by this antibody ( Fig. 2A,B) . The maternal cells had the morphology of hepatocytes and were not located in the vicinity of biliary ducts. In these tissue sections, as in other tissues, an anti-CD45 antibody served as an internal control for hematopoietic cells, confirming that the maternal hepatocytes did not express CD45 and thus were not hematopoietic cells overlying the hepatocytes. Maternal nuclei were identified in 6 of 7 subjects and ranged from 1 in 6000 to 3 in 2000 hepatocytes assayed (0.017% to 0.15%).
Studies of the lung employed immunohistochemistry with antibodies to epithelial cells, endothelial cells, and type II pneumocytes. One maternal cell expressed surfactant protein B and thus was a type II pneumocyte (not shown), and another maternal cell expressed cytokeratin, indicating that it was an epithelial cell ( Fig. 2C,D) . Other maternal cells in the lung did not stain for surfactant, the endothelial cell marker Von Willebrand Factor, or for the epithelial cell marker cytokeratin recognized by the AE3 antibody and thus remain uncharacterized. In the heart most of the maternal cells expressed sarcomeric a-actin, as previously reported ( Fig. 2E,F) [12] , but some expressed neither CD45 nor sarcomeric a-actin and thus could be endothelial cells, pericytes, fibroblasts, epicardium, valve tissue, or stem cells (Fig. 2G,H) .
In the kidney, 2 different antibodies specific for cytokeratins expressed by renal tubular epithelial cells were used (CAM5.2 and AE3). All maternal cells identified were incorporated into the structure of renal tubular cells (found in 2 of 3 subjects for which kidney tissue was available; Fig. 3A-C) . Chimeric maternal cells all expressed cytokeratins and had the morphology typical of tubular epithelial cells. Maternal tubular epithelial cells were present at levels of 0.025% to 0.3% of host epithelial cells. In the pancreas, maternal b-islet cells were identified by immunohistochemistry for insulin expression within the cytoplasm and a-cells were identified by glucagon expression (Fig. 3D,E) . Islet b cells expressing insulin were clearly distinguished from the a-islet cells expressing glucagon by virtue of different substrate colors within the same fields. Among islet b cells, up to 1.9% were maternal. No maternal cells were identified that expressed glucagon. Maternal hematopoietic cells expressing either CD45 or CD3 were found only rarely in the hearts affected by NLS, and they were not found in any other tissues. In order to determine whether or not MMc is associated with inflammation, as would be expected if maternal cells were targets of host immunity, we examined adjacent sections stained with hematoxylin and eosin. Active inflammation was defined by areas in which neutrophils or mononuclear cells were infiltrating areas in which they do not usually reside. This was detected in the presence or absence of tissue destruction or fibrosis. Areas with lymphoid tissue or extramedullary hematopoiesis were not considered to be inflammatory. In the liver, chronic inflammatory infiltrates were present in 2 subjects, and extramedullary hematopoiesis was present in 6 subjects ( Table 1) . Maternal microchimerism was not found in any Table 2 . Efficiency of fluorescent in situ hybridization (FISH) for X-and Y-chromosomes (percent of nuclei with 2 distinct sex chromosomes) after immunohistochemistry in different tissue types. The efficiency depends on fixation conditions of the tissue, the antibody used, and the tissue type of these areas with hematopoietic cells; it was found in areas of normal, unperturbed tissue in all organs.
DISCUSSION
We have demonstrated that maternal cells that presumably passed into the fetus during pregnancy can home to tissues and resemble myocardial, hepatic, renal, pulmonary, and pancreatic cells by morphology and tissuespecific expression. The highest levels were found in liver, kidney, and pancreas. Previous studies have demonstrated maternal cells in the blood and tissues, but early attempts to characterize them described hematopoietic cells [7, 8, 20] . In contrast, we found mostly parenchymal and only rare maternal hematopoietic cells in tissues.
How maternal parenchymal cells come to be incorporated into a child's tissues is not known. The MMc was of mesoderm, endoderm, and ectodermal cell types. Thus, maternal stem cells could have engrafted during the 1st trimester and differentiated alongside the child's cells. Alternatively, the tissue-specific maternal cells could have been derived from circulating maternal stem cells that transdifferentiated into organ tissues, as has been suggested in the setting of stem cell transplantation [22] . Circulating maternal cells could have been precursors to tissue-specific cells, or they could have differentiated after migrating into the tissues.
Another possibility that cannot be ruled out in the current study is that maternal cells are not actually differentiated tissue-specific cells but rather are hematopoietic cells that have fused with fetal cells, a phenom- Figure 2 . Maternal cells characterized in infant tissues. Immunohistochemistry was performed with antibodies to tissue-specific proteins and was followed by fluorescent in situ hybridization (FISH) for X-and Y-chromosomes. Arrows designate female (presumed maternal) nuclei with 2 red X-chromosomes among the infant's male nuclei, each with 1 red Xchromosome and 1 green Ychromosome. A, B. One maternal hepatocyte expressed cytokeratin (brown) throughout the cytoplasm surrounding the maternal nucleus incorporated into the hepatic tissue structure (320, inset 3100). C, D. Maternal epithelial cell in the lung identified by cytokeratin expression (brown, arrows) but not the endothelial cell marker Von Willebrand Factor (bluegray stain, white arrowhead; 340). E, F. Maternal myocardial cell identified by expression of sarcomeric aactin (brown). The maternal cell does not express CD45 (blue-gray), which serves as an additional internal control, confirming that the maternal cell is not a hematopoietic cell overlying a myocardial cell (340). G, H. Maternal cell in the myocardium that does not express CD45 or sarcomeric aactin (340). enon that has been described in vitro [26, 27] and in vivo and that can result in multinucleated cells in which each nucleus appears to be a normal diploid nucleus [28, 29] . In the latter mouse model, transplanted hematopoietic stem cells fused with hepatocytes and expressed genes at a high enough level to replace an enzyme deficiency. Maternal cells could likewise fuse with a child's cells, leading to expression of maternal HLA molecules, which could be recognized by the child's immune system as being foreign. Thus, although it is not possible in our study to determine whether the maternal cells have differentiated or fused with fetal cells, even fused maternal-fetal cells Figure 2 . A. A maternal (female) cell in a cross section of a renal tubule was identified by fluorescence in situ hybridization (FISH) (340). B, C. Immunohistochemistry was performed with antibodies to cytokeratin (brown) and CD45 (blue-gray). A representative maternal cell stained with antibodies to cytokeratin (brown) and was incorporated into a renal tubule (340, inset 3100). C, D. Maternal b-islet cell in the pancreas. Immunohistochemistry was performed with antibodies to insulin (brown) and glucagon (gray). Insulin expression is seen throughout the tissue and in the cytoplasm surrounding the maternal nucleus (arrowhead, 340). could be pathogenic. In any case, the rate of naturally occurring MMc appears not to be of the quality and/or quantity to replace functional host cells in cases of congenital enzyme deficiencies, as has been demonstrated for transplanted cells [29] . Whether MMc could be potentiated to restore fetal deficiencies is not known, but such a process would be advantageous because of the inherent immune tolerance to maternal antigens.
The female cells found in male tissues were presumed to be maternal, but there are other potential sources of female cells. Twin/twin transfusion is one alternative source of microchimerism. The subjects in this study had no known twins, but the vanishing twin phenomenon is not unusual [30] . Also, female cells from a previous fetus carried by the mother could persist through a subsequent pregnancy and then pass into the subject fetus. Three subjects had received blood transfusions, which can lead to microchimerism [31] , but chimerism from female blood donors is unlikely, because blood transfused into newborns is routinely irradiated to eliminate live cells. Therefore, the female cells detected in newborn tissues in this study are most likely to be of maternal origin. Definitive evidence for the source of female cells could be obtained if maternal DNA were available from the mothers by detection of noninherited, nonshared maternal alleles of polymorphic genes, as has been employed previously in blood samples [2, 4, 18, 32] .
That MMc is common in the absence of inflammatory disease implies a normal lasting tolerance to maternal antigens. Such anti-maternal T-lymphocyte tolerance has been demonstrated in a mouse model, with the requirement for nursing [33] , perhaps through mechanisms of oral tolerance to maternal HLA proteins in the milk [34] . The mouse, however, is a limited model for events occurring during human pregnancy because of the physiological, immunological, and anatomical differences between species [35, 36] .
Maternal microchimerism could contribute to autoimmune diseases or participate in a secondary event in pathogenesis, amplified as part of an attempt to regenerate damaged tissue, as has been described for circulating stem cells in myocardial injury [37] [38] [39] [40] , diabetes [41] , and ischemic renal injury [42] . Stem cell-derived tissue may be beneficial, improving organ function [29, 43, 44] . An understanding of the mechanisms of tissue regeneration by adult stem cells may lead to new cellular treatments for organ failure through delivery of new stem cells to aid in tissue regeneration [29, 45, 46] . That MMc is tolerated by the host immune system indicates the potential for maternal stem cells to serve as donor cells in tissue regeneration protocols. Because autoimmune disease is also characterized by tissue injury and regeneration, a similar mechanism of stem cell recruitment may contribute to organ repair in these patients. Recruited precursor stem cells could be of maternal origin, as MMc has been identified in the murine bone marrow [47] [48] [49] [50] . However, many of the tissues included in our study were not injured and thus would only have experienced normal cell turnover rather than overall regeneration, yet many of the tissues in our study contained maternal cells, indicating that MMc within tissues may be a normal phenomenon. Similar observations have been made for FMc, which has been found in multiple tissue types, both those that are healthy and those that are targets of autoimmunity [51, 52] .
In summary, maternal cells that travel into a fetus can migrate into the tissues that are target organs for autoimmune disease and express tissue-specific proteins. We found that MMc in tissues was frequent, present in most subjects and representing between 0.05% and 0.9% of all cells and up to 1.9% of specific differentiated cell types. Maternal microchimerism was not necessarily associated with inflammation. Chimeric maternal cells may play different roles during different times of development-early in gestation they may be benign and simply part of normal tissue differentiation; later they may be recognized as foreign, and thus immunostimulatory. Future studies will be necessary to determine how widespread this phenomenon is at older ages and to identify the beneficial or deleterious roles that maternal cells may play in children.
